Acquired bullous epidermolysis: complexity of diagnostics

Cover Page

Abstract


The article describes the case of acquired bullous epidermolysis in a woman of 45 years old, suffering from a disease from 2.5 years. As a child, she was diagnosed with herpetiform dermatitis on the base of a clinical picture and histological data. After the period of puberty, when in addition to skin blistering a lesion of the oral mucosa, dystrophy and absence of nail plates, contracture of the 2 fingers of the hands arose, the diagnosis was changed to dystrophic congenital bullous epidermolysis, which did not contradict with re-histological examination of the skin. In order to clarify the diagnosis, another biopsy of the leg skin was performed in 2016. The light microscopy data corresponded to the herpetiform dermatitis or vesicular form of the bullous pemphigoid, the acquired bullous epidermolysis was not also excluded. Indirect RIF allowed to reject the diagnosis of herpetiform dermatitis. The possibility of bullous pemphigoid developing on the background of preexisting congenital bullous epidermolysis was investigated by immunofluorescence mapping with antibodies to 13 structural proteins of the dermo-epidermal junction. Expression of all the studied proteins corresponded to that of healthy individuals, which conflicted with the diagnosis of congenital bullous epidermolysis. Additional immunofluorescence study of the sites of spontaneous cleavage of the biopsy specimen, as well as of n- and u-patterns in the structure of the luminescence line, made possible to exclude the bullous pemphigoid. So, the use of a complex of immunomorphological methods helped to establish the correct diagnosis.

About the authors

V. I. Al'banova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Author for correspondence.
Email: albanova@rambler.ru

Russian Federation

M. A. Nefedova

State Research Center of Dermatovenereology and Cosmetology, Ministry of Healthcare of the Russian Federation

Email: noemail@neicon.ru

Russian Federation

References

  1. Baum S., Sakka N., Artsi O. et al. Diagnosis and classification of autoimmune blistering diseases. Autoimmunity Reviews 2014; 13: 482-489.
  2. Ludwig R. J. Clinical presentation, pathogenesis, diagnosis, and treatment of epidermolysis bullosa acquisita. ISRN Dermatology 2013; 2013: 812029
  3. Gupta R., Woodley D. T., Chen M. Epidermolysis bullosa acquisita. Clin Dermatol 2012; 30: 60-69.
  4. Ishii N., Hamada T., Dainichi T. et al. Epidermolysis bullosa acquisita: What’s new? The Journal of Dermatology 2010; 37: 220-230.
  5. Chikin V. V., Znamenskaya L. F., Nefedova M. A. et al. Epidermolysis bullosa acquisita. Vestn Dermatol Venerol 2015; (3): 109-118. [Чикин В. В, Знаменская Л. Ф., Нефедова М. А. и др. Приобретенный буллезный эпидермолиз: описание клинического случая. Вестн дерматол венерол 2015; (3): 109-118]
  6. Goyal N., Rao R., Balachandran C. et al. Childhood Epidermolysis Bullosa Acquisita: Confirmation of Diagnosis by Skin Deficient in Type VII Collagen, Enzyme-linked Immunosorbent Assay, and Immunoblotting. Ind J Dermatol 2016; 61 (3): 329-332.
  7. Arpey C. J., Elewski B. E., Moritz D. K. et al. Childhood epidermolysis bullosa acquisita. Report of three cases and review of literature. J Amer Acad Dermatol 1991; 24 (5 Pt 1): 706- 714.
  8. Su J. C., Varigos G. A., Dowling J. Epidermolysis bullosa acquisita in childhood. Austral J Dermatol 1998; 39: 38-41.
  9. Edwards S., Wakelin S. H., Wojnarowska F. et al. Bullous pemphigoid and epidermolysis bullosa acquisita: Presentation, prognosis, and immunopathology in 11 children. Pediat Dermatol 1998; 15: 184-190
  10. Chorzelski T., Karczewska K., Dyduch A. et al. Epidermolysis bullosa acquisita in a 4-year-old boy. Pediat Dermatol 2000; 17: 157-158.
  11. Schmidt E., Höpfner B., Chen M. et al. Childhood epidermolysis bullosa acquisita: A novel variant with reactivity to all three structural domains of type VII collagen. Brit J Dermatol 2002; 147: 592-597.
  12. Roenigk H. H. Jr., Ryan J. G., Bergfeld W. F. Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Arch Dermatol 1971; 103 (1): 1-10.
  13. Antiga E., Caproni M. The diagnosis and treatment of dermatitis herpetiformis. Clin Cosmet Invest Dermatol 2015; 8: 257-265.
  14. Onodera Y., Shimizu H., Hashimoto T. et al. Difference in binding sites of autoantibodies against 230- and 170-kD bullous pemphigoid antigens on salt-split skin. J Invest Dermatol 1994; 102 (5): 686-690.
  15. Terra J. B., Meijer J. M., Jonkman M. F. et al. The n- versus u-serration is a learnable criterion to differentiate pemphigoid from epidermolysis bullosa acquisita in direct immunofluorescence serration pattern analysis. Brit J Dermatol 2013; 169 (1): 100-105.
  16. Kopecki Z., Ludwig R. J., Cowin A. J. Cytoskeletal Regulation of Inflammation and Its Impact on Skin Blistering Disease Epidermolysis Bullosa Acquisita. Int J Molec Sci 2016; 17 (7).
  17. Kim J. H., Kim Y. H., Kim S. C. Epidermolysis bullosa acquisita: a retrospective clinical analysis of 30 cases. Acta Dermovenereologica 2011; 91 (3): 307-312.
  18. Sami N. Mycophenolate mofetil (MMF) in the treatment of epidermolysis bullosa acquisita (EBA) long-term follow-up. JAAD Case Reports. 2015; 1 (5): 321-323.

Statistics

Views

Abstract - 618

PDF (Russian) - 357

PlumX

Dimensions


Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies